Colby Stong

2 weeks ago | rheumatologyadvisor.com | Colby Stong

Bimekizumab was associated with sustained skin clearance in patients with moderate to severe plaque psoriasis through 4 years of treatment, according to study results published in the Journal of the American Academy of Dermatology. Researchers reported the end-of-study 4-year data from BE BRIGHT (ClinicalTrials.gov Identifier: NCT03598790), an open-label extension (OLE) trial that evaluated the long-term efficacy and safety of bimekizumab in patients with moderate to severe plaque psoriasis.

2 weeks ago | neurologyadvisor.com | Colby Stong

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a significant decrease in apnea-hypopnea index (AHI) among patients with moderate to severe obstructive sleep apnea (OSA) and without diabetes, although they may lead to an increased risk of gastrointestinal side effects, according to study findings published in Sleep Medicine.

2 weeks ago | gastroenterologyadvisor.com | Colby Stong

Ambulatory acute kidney injury (A-AKI) is common among individuals with cirrhosis, is linked to high 90-day mortality, and is often underrecognized, according to study results published in Clinical Gastroenterology and Hepatology. To fill a knowledge gap on A-AKI incidence, risk factors, and outcomes among individuals with cirrhosis, investigators conducted a retrospective cohort study.

3 weeks ago | pulmonologyadvisor.com | Colby Stong

Prepandemic severe spirometric obstruction, spirometric restriction, and increased emphysema on computed tomography (CT) are associated with a higher risk for severe COVID-19, according to a study in the American Journal of Respiratory and Critical Care Medicine. Researchers evaluated the risk for severe COVID-19 in patients with and without impaired lung health using data from the Collaborative Cohort of Cohorts for COVID-19 Research (C4R).

3 weeks ago | gastroenterologyadvisor.com | Colby Stong

Patients with primary sclerosing cholangitis-inflammatory bowel disease (PSC-IBD) who had a liver transplant (LT) have a decreased risk for colorectal neoplasia compared with individuals with PSC-IBD who did not undergo LT, according to study results published in Clinical Gastroenterology and Hepatology. Researchers conducted a multicenter retrospective cohort study to assess the effects of LT on colorectal cancer (CRC) risk among patients with concomitant PSC and IBD.